Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Melanoma 21 Brain Neoplasms 7 Neoplasms 5 Colorectal Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Pancreatic Neoplasms 4 Lung Neoplasms 4 Ovarian Neoplasms 3 Neoplasm Metastasis 3 Multiple Myeloma 3 Hematologic Neoplasms 3 Thyroid Neoplasms 2 Lymphoma 2 Leukemia, Hairy Cell 2 Glioma 2 Endometrial Neoplasms 2 Colonic Neoplasms 2 Breast Neoplasms 2 Uveal Melanoma 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Solid Tumor 1 Skin Neoplasms 1 Recurrence 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Peripheral Nervous System Neoplasms 1

Interventions

Temozolomide 46 Radiotherapy 36 Bevacizumab 34 Carmustine 13 Erlotinib Hydrochloride 11 Irinotecan 10 sargramostim 7 Thalidomide 7 Chemotherapy, Adjuvant 7 Carboplatin 7 Radiation 6 pembrolizumab 5 Topotecan 5 Magnetic Resonance Spectroscopy 5 Filgrastim 5 Drug Therapy 5 Cyclophosphamide 5 aldesleukin 4 Tamoxifen 4 Surgical Procedures, Operative 4 Sorafenib 4 O(6)-benzylguanine 4 Gefitinib 4 Etoposide 4 Celecoxib 4 cediranib 3 Radiotherapy, Intensity-Modulated 3 Radiotherapy, Conformal 3 Peripheral Blood Stem Cell Transplantation 3 Imatinib Mesylate 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Gliosarcoma × binimetinib × Clear all

NCT03973918 2024-10-31

BRAF

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Terminated

5 enrolled 15 charts

Astrocytoma, Glioblastoma, Glioma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡